Browsing Tag
ALTO-101
1 post
Is biomarker-enriched trial design the key to solving schizophrenia cognition failures?
Can biomarker-enriched trials solve schizophrenia cognition failures? Explore Alto Neuroscience’s strategy and what Phase 2 data could mean next.